Persius/hicric huggingface dataset:
Appeal type: unknown
Decision: unknown

 
The rules say that plans must pay for a medical service or item if regular Medicare would pay for it in this case. 
You can find this rule at 42 Code of Federal Regulations (CFR) Section 422.101. 
 
The rules say that Medicare may cover a drug or biological if it is safe and effective and otherwise reasonable 
and necessary. You can find this rule in the Centers for Medicare and Medicaid Services, Internet Only 
Manual, Publication 100-02, Medicare Benefit Policy Manual, Chapter 15, Section 50.4.1. 
  
Medicare rules also allow the plan to use step therapy. This is the process of beginning drug therapy for a 
medical condition with "preferred" (or more cost-effective) on-formulary drug alternative(s) and progressing to 
other drug therapies only as necessary. A plan must grant an exception to its step therapy rules if it determines 
that the requested drug is medically necessary, consistent with the prescriber's statement. The statement must 
show that the step therapy drugs: have been ineffective in treating the enrollee; or are likely to be ineffective or 
adversely affect the drug's effectiveness or patient compliance; or are likely to cause an adverse reaction or 
other harm to the enrollee.  
 
Medicare Advantage plans should ensure that new step therapy requirements do not disrupt ongoing Part B 
drug therapies for enrollees. Step therapy may only be applied to new prescriptions or administrations of Part B 
drugs for enrollees that are not actively receiving the affected medication. You can find this information at 42 
CFR Sections 422.2 and 422.136. 
 
If you want to read these Medicare rules, you can go to this website www.medicareappeal.com. 
 
The Plan contract says that the Plan covers items and services in accordance with Medicare rules. The contract 
says that the Plan has step therapy requirements for certain Medicare Part B covered drugs/biologicals. 
Enrollees may be required to try a preferred drug before the Plan will approve the requested medication. You 
can find this information on pages 18-19 in the Plan's 2023 Evidence of Coverage.
Appeal type: unknown
Decision: unknown

 
The rules say that plans must pay for a medical service or item if regular Medicare would pay for it in this case. 
You can find this rule at 42 Code of Federal Regulations (CFR) Section 422.101. 
 
The rules say that Medicare may cover a drug or biological if it is safe and effective and otherwise reasonable 
and necessary. You can find this rule in the Centers for Medicare and Medicaid Services, Internet Only 
Manual, Publication 100-02, Medicare Benefit Policy Manual, Chapter 15, Section 50.4.1. 
  
Medicare rules also allow the plan to use step therapy. This is the process of beginning drug therapy for a 
medical condition with "preferred" (or more cost-effective) on-formulary drug alternative(s) and progressing to 
other drug therapies only as necessary. A plan must grant an exception to its step therapy rules if it determines 
that the requested drug is medically necessary, consistent with the prescriber's statement. The statement must 
show that the step therapy drugs: have been ineffective in treating the enrollee; or are likely to be ineffective or 
adversely affect the drug's effectiveness or patient compliance; or are likely to cause an adverse reaction or 
other harm to the enrollee.  
 
Medicare Advantage plans should ensure that new step therapy requirements do not disrupt ongoing Part B 
drug therapies for enrollees. Step therapy may only be applied to new prescriptions or administrations of Part B 
drugs for enrollees that are not actively receiving the affected medication. You can find this information at 42 
CFR Sections 422.2 and 422.136. 
 
If you want to read these Medicare rules, you can go to this website www.medicareappeal.com. 
 
The Plan contract says that the Plan covers items and services in accordance with Medicare rules. The contract 
says that the Plan has step therapy requirements for certain Medicare Part B covered drugs/biologicals. 
Enrollees may be required to try a preferred drug before the Plan will approve the requested medication. You 
can find this information in Chapter 4 on pages 72 to 73 of the Plan's 2023 Evidence of Coverage.
Appeal type: unknown
Decision: unknown

 
The rules say that plans must pay for a medical service or item if regular Medicare would pay for it in this case. 
You can find this rule at 42 Code of Federal Regulations (CFR) Section 422.101. 
 
The rules state that patients meeting benefit category requirements for Medicare coverage of a partial 
hospitalization program (PHP) comprise two groups: those patients who are discharged from an inpatient 
  
  hospital treatment program, and the PHP is in lieu of continued inpatient treatment; or those patients who, in 
the absence of partial hospitalization, would be at reasonable risk of requiring inpatient hospitalization. Where 
partial hospitalization is used to shorten an inpatient stay and transition the patient to a less intense level of 
care, there must be evidence of the need for the acute, intense, structured combination of services provided by a 
PHP. Recertification must address the continuing serious nature of the patients psychiatric condition requiring 
active treatment in a PHP. 
 
Patients admitted to a PHP must be under the care of a physician who certifies the need for partial 
hospitalization and require a minimum of 20 hours per week of therapeutic services, as evidenced by their plan 
of care. The patients also require a comprehensive, structured, multimodal treatment requiring medical 
supervision and coordination, provided under an individualized plan of care, because of a mental disorder 
which severely interferes with multiple areas of daily life, including social, vocational, and/or educational 
functioning. Such dysfunction generally is of an acute nature. In addition, PHP patients must be able to 
cognitively and emotionally participate in the active treatment process, and be capable of tolerating the 
intensity of a PHP program. You can find these rules in Medicare Benefit Policy Manual Chapter 6, Section 
70.3(B). 
 
If you want to read these Medicare rules, you can go to this website www.medicareappeal.com. 
 
The Plan contract says that the Plan covers items and services in accordance with Medicare rules.
Appeal type: unknown
Decision: unknown

 
The rules say that plans must pay for a medical service or item if regular Medicare would pay for it in this case. 
You can find this rule at 42 Code of Federal Regulations (CFR) Section 422.101. 
 
The rules state that institutional providers billing clinical trial service(s) must report ICD-9 diagnosis code 
V70.7 if ICD-9 is applicable or, if ICD-10-CM is applicable, ICD-10 diagnosis code Z006 in either the primary 
or secondary position and a condition code 30 regardless of whether all services are related to the clinical trial 
or not. You can find this rule in the Centers for Medicare and Medicaid Services, Internet Only Manual, 
Medicare Claims Processing Manual, Chapter 32, Section 69.6. 
 
If you want to read these Medicare rules, you can go to this website www.medicareappeal.com. 
 
The Plan contract says that the Plan covers items and services in accordance with Medicare rules.
Appeal type: unknown
Decision: unknown

 
The rules say that plans must pay for a medical service or item if regular Medicare would pay for it in this case. 
You can find this rule at 42 Code of Federal Regulations (CFR) Section 422.101. 
 
The rules say that Medicare may cover a drug or biological if it is safe and effective and otherwise reasonable 
and necessary. You can find this rule in the Centers for Medicare and Medicaid Services, Internet Only 
Manual, Publication 100-02, Medicare Benefit Policy Manual, Chapter 15, Section 50.4.1. 
  
Medicare rules also allow the plan to use step therapy. This is the process of beginning drug therapy for a 
medical condition with "preferred" (or more cost-effective) on-formulary drug alternative(s) and progressing to 
other drug therapies only as necessary. A plan must grant an exception to its step therapy rules if it determines 
that the requested drug is medically necessary, consistent with the prescriber's statement. The statement must 
show that the step therapy drugs: have been ineffective in treating the enrollee; or are likely to be ineffective or 
adversely affect the drug's effectiveness or patient compliance; or are likely to cause an adverse reaction or 
other harm to the enrollee.  
 
Medicare Advantage plans should ensure that new step therapy requirements do not disrupt ongoing Part B 
drug therapies for enrollees. Step therapy may only be applied to new prescriptions or administrations of Part B 
drugs for enrollees that are not actively receiving the affected medication. You can find this information at 42 
CFR Sections 422.2 and 422.136. 
 
If you want to read these Medicare rules, you can go to this website www.medicareappeal.com. 
 
The Plan contract says that the Plan covers items and services in accordance with Medicare rules. The contract 
says that the Plan has step therapy requirements for certain Medicare Part B covered drugs/biologicals. 
Enrollees may be required to try a preferred drug before the Plan will approve the requested medication. You 
can find this information on pages 17-18 in the Plan's 2023 Evidence of Coverage.
Appeal type: unknown
Decision: unknown

 
The rules say that plans must pay for a medical service or item if regular Medicare would pay for it in this case. 
You can find this rule at 42 Code of Federal Regulations (CFR) Section 422.101. 
 
  
  The rules say that Medicare plans must make reasonable and diligent efforts to gather and forward information 
to the Independent Review Entity (IRE). You can find this information in the Centers for Medicare and 
Medicaid Services, Internet Only Manual, Parts C & D Enrollee Grievances, Organization/Coverage 
Determinations, and Appeals Guidance Manual, Section 50.12.1. 
 
The rules say that Medicare Part B coverage is available for outpatient Opioid Treatment Program services 
provided by hospitals, critical access hospitals (CAHs), and Free-Standing Opioid Treatment Program 
facilities. You can find this information in the Centers for Medicare and Medicaid Services (CMS), Internet-
Only Manual, Publication 100-04, Medicare Claims Processing Manual Chapter 39, Section 50. 
 
If you want to read these Medicare rules, you can go to this website www.medicareappeal.com. 
 
The Plan contract says that the Plan covers items and services in accordance with Medicare rules.
Appeal type: unknown
Decision: unknown

 
The rules say that plans must pay for a medical service or item if regular Medicare would pay for it in this case. 
You can find this rule at 42 Code of Federal Regulations (CFR) Section 422.101. 
 
The rules say that spinal cord stimulators may be covered as therapy for relief of chronic intractable pain, 
provided that the following conditions are met: 
 
a) The implantation of the stimulator is used only as a late resort (if not a last resort) for patients with chronic 
intractable pain;  
b) With respect to item a, other treatment modalities (pharmacological, surgical, physical, or psychological 
therapies) have been tried and did not prove satisfactory, or are judged to be unsuitable or contraindicated for 
the given patient;  
c) Patients have undergone careful screening, evaluation and diagnosis by a multidisciplinary team prior to 
implantation. (Such screening must include psychological, as well as physical evaluation);  
d) All the facilities, equipment, and professional and support personnel required for the proper diagnosis, 
treatment training, and follow up of the patient (including that required to satisfy item c) must be available; and  
e) Demonstration of pain relief with a temporarily implanted electrode precedes permanent implantation. 
You can find this rule in the Centers for Medicare and Medicaid Services, Internet Only Manual, Medicare 
National Coverage Determinations Manual, Section 160.7(B). 
 
If you want to read these Medicare rules, you can go to this website www.medicareappeal.com.
Appeal type: unknown
Decision: unknown

 
The rules say that plans must pay for a medical service or item if regular Medicare would pay for it in this case. 
You can find this rule at 42 Code of Federal Regulations (CFR) Section 422.101. 
 
The rules say that a patient lift is covered if transfer between bed and a chair, wheelchair, or commode is 
required and, without the use of a lift, the beneficiary would be bed confined. 
 
A patient lift described by codes E0630, E0635, E0639, or E0640 is covered if the basic coverage criteria are 
met. If the coverage criteria are not met, the lift will be denied as not reasonable and necessary. 
 
A multi-positional patient transfer system (E0636, E1035, E1036) is covered if both of the following criteria 1 
and 2 are met: 1. The basic coverage criteria for a lift are met; and 
2. The beneficiary requires supine positioning for transfers 
 
If either criterion 1 or 2 is not met, codes E0636, E1035, and E1036 will be denied as not reasonable and 
necessary. 
 
If coverage is provided for code E1035 or E1036, payment will be discontinued for any other mobility assistive 
equipment, including but not limited to: canes, crutches, walkers, rollabout chairs, transfer chairs, manual 
wheelchairs, power-operated vehicles, or power wheelchairs. 
 
You can find this information in the Local Coverage Determination (LCD): Patient Lifts (L33799). 
 
If you want to read these Medicare rules, you can go to this website www.medicareappeal.com.
Appeal type: unknown
Decision: unknown

 
The rules say that plans must pay for a medical service or item if regular Medicare would pay for it in this case. 
You can find this rule at 42 Code of Federal Regulations (CFR) Section 422.101. 
 
The rules say that MRIs are covered when medically necessary and reasonable for the diagnosis or treatment of 
the specific patient involved. You can find this rule in the Centers for Medicare and Medicaid Services, Internet 
Only Manual, Publication 100-03, Medicare National Coverage Determinations Manual, Section 220.2(B). 
 
The rules say that magnetic resonance angiography (MRA) is appropriately used to verify the presence of a 
condition, suspected because of findings from another test (usually an imaging study). For example, a patient 
who presents with a transient ischemic attack (TIA) should not undergo MRA simply because he might have a 
lesion which is amenable to surgery. However, if that patient has a carotid bruit and is found by Doppler study 
to have carotid stenosis, an MRA may be appropriate to evaluate the stenotic section of artery for surgical 
intervention. Please note that the anticipated surgery may be a percutaneous procedure such as carotid 
angioplasty with stent insertion. Another patient may present with a headache; it is not appropriate to proceed 
directly to MRA to rule out the possibility of an intracranial aneurysm. However, if that patient was found to 
have a clinically significant amount of blood in the cerebrospinal fluid, or the patient demonstrated signs and 
symptoms strongly suggesting an unruptured intracranial aneurysm, an MRA (or cerebral angiogram) may be 
appropriate. An MRA is not considered medically reasonable and necessary for screening asymptomatic 
patients for intracranial aneurysms. You can find this rule in the Local Coverage Determination (LCD) - 
Magnetic Resonance Angiography (MRA) (L34865) - Effective July 1, 2020. 
 
If you want to read these Medicare rules, you can go to this website www.medicareappeal.com. 
 
The Plan contract says that the Plan covers items and services in accordance with Medicare rules.
Appeal type: unknown
Decision: unknown

 
The rules say that plans must pay for a medical service or item if regular Medicare would pay for it in this case. 
You can find this rule at 42 Code of Federal Regulations (CFR) Section 422.101. 
 
The rules state that for drug testing to be covered the patients medical record must include an appropriate 
testing frequency based on the stage of treatment or recovery, the rationale for the drug/drug classes ordered, 
and the results are documented in the medical record and used to direct care. This rule is found in Local 
Coverage Determination (LCD): Controlled Substance Monitoring and Drugs of Abuse Testing (L36393). 
 
If you want to read these Medicare rules, you can go to this website www.medicareappeal.com. 
 
The Plan contract says that the Plan covers items and services in accordance with Medicare rules.
Appeal type: unknown
Decision: unknown

 
The rules say that plans must pay for a medical service or item if regular Medicare would pay for it in this case. 
You can find this rule at 42 Code of Federal Regulations (CFR) Section 422.101. 
 
The rules state that only one hospital inpatient or observation discharge day management service is payable per 
patient per hospital stay. You can find this rule in the Centers for Medicare and Medicaid Services, Internet 
Only Manual, Medicare Claims Processing Manual, Chapter 12, Section 30.6.9.2. 
 
If you want to read these Medicare rules, you can go to this website www.medicareappeal.com. 
 
The Plan contract says that the Plan covers items and services in accordance with Medicare rules.
Appeal type: unknown
Decision: unknown

 
The rules say that plans must pay for a medical service or item if regular Medicare would pay for it in this case. 
You can find this rule at 42 Code of Federal Regulations (CFR) Section 422.101. 
 
The rules say that a knee orthosis, with an adjustable flexion and extension joint that provides both medial-
lateral and rotation control (L1852) is covered if the beneficiary has had recent injury to or a surgical procedure 
on the knee(s). It is also covered for a beneficiary who is ambulatory and has knee instability. You can find this 
rule in the Local Coverage Determination (LCD) - Knee Orthoses (L33318) - Effective January 1, 2020. 
 
The rules say that knee instability must be documented by examination of the beneficiary and objective 
description of joint laxity (e.g., varus/valgus instability, anterior/posterior Drawer test). You can find this rule 
in the Local Coverage Determination (LCD) - Knee Orthoses (L33318) - Effective January 1, 2020. 
 
If you want to read these Medicare rules, you can go to this website www.medicareappeal.com. 
 
The Plan contract says that the Plan covers items and services in accordance with Medicare rules.
Appeal type: unknown
Decision: unknown

 
The rules say that plans must pay for a medical service or item if regular Medicare would pay for it in this case. 
You can find this rule at 42 Code of Federal Regulations (CFR) Section 422.101. 
 
The rules state that beginning January 1, 2021, the cinacalcet oral drug is eligible for consideration as an ESRD 
outlier service: 
 
- Report the number of tablets or pills, not the number of units (for example, milligrams) 
- Report revenue code 250 with the national drug code 
- Do not use revenue code 0636 with HCPCS code J0604. 
 
You can find this information in the Centers for Medicare and Medicaid Services, Internet-Only Manual, 
Medicare's Learning Network (MLN) dated September 23, 2021: https://www.cms.gov/outreach-and-
educationoutreachffsprovpartprogprovider-partnership-email-archive/2021-09-23-mlnc 
 
If you want to read these Medicare rules, you can go to this website www.medicareappeal.com. 
 
The Plan contract says that the Plan covers items and services in accordance with Medicare rules.
Appeal type: unknown
Decision: unknown

 
The rules say that plans must pay for a medical service or item if regular Medicare would pay for it in this case. 
You can find this rule at 42 Code of Federal Regulations (CFR) Section 422.101. 
 
The rules say that medically necessary services are those that are reasonable and necessary for the diagnosis or 
treatment of an illness or injury. Medically necessary services include services to improve the functioning of a 
malformed body member. You can find this rule in the Social Security Act, Section 1862(a)(1)(A). 
 
The rules say that L5301, L5540, L5321, L5590 should not be used when billing a replacement socket for an 
existing prosthesis. The use of L5301, L5540, L5321, L5590 with a replacement socket is incorrect coding 
(unbundling). Code L5999 (LOWER EXTREMITY PROSTHESIS, NOT OTHERWISE SPECIFIED) must 
not be used to bill for any features or functions included in the socket or addition codes. Use of L5999 is 
incorrect coding (unbundling). You can find this rule in the Local Coverage Article Lower Limb Prostheses - 
Policy Article A52496. 
 
If you want to read these Medicare rules, you can go to this website www.medicareappeal.com. 
 
The Plan contract says that the Plan covers items and services in accordance with Medicare rules.
Appeal type: unknown
Decision: unknown

 
The rules say that plans must pay for a medical service or item if regular Medicare would pay for it in this case. 
You can find this rule at 42 Code of Federal Regulations (CFR) Section 422.101. 
 
The rules say that Medicare may cover a drug or biological if it is safe and effective and otherwise reasonable 
and necessary. You can find this rule in the Centers for Medicare and Medicaid Services, Internet Only 
Manual, Publication 100-02, Medicare Benefit Policy Manual, Chapter 15, Section 50.4.1. 
  
Medicare rules also allow the plan to use step therapy. This is the process of beginning drug therapy for a 
medical condition with "preferred" (or more cost-effective) on-formulary drug alternative(s) and progressing to 
other drug therapies only as necessary. A plan must grant an exception to its step therapy rules if it determines 
that the requested drug is medically necessary, consistent with the prescriber's statement. The statement must 
show that the step therapy drugs: have been ineffective in treating the enrollee; or are likely to be ineffective or 
adversely affect the drug's effectiveness or patient compliance; or are likely to cause an adverse reaction or 
other harm to the enrollee.  
 
Medicare Advantage plans should ensure that new step therapy requirements do not disrupt ongoing Part B 
drug therapies for enrollees. Step therapy may only be applied to new prescriptions or administrations of Part B 
drugs for enrollees that are not actively receiving the affected medication. You can find this information at 42 
CFR Sections 422.2 and 422.136. 
 
If you want to read these Medicare rules, you can go to this website www.medicareappeal.com. 
 
The Plan contract says that the Plan covers items and services in accordance with Medicare rules. The contract 
says that the Plan has step therapy requirements for certain Medicare Part B covered drugs/biologicals. 
Enrollees may be required to try a preferred drug before the Plan will approve the requested medication. You 
can find this information on pages 72-73 in the Plans 2023 Evidence of Coverage.